Accumulation of FoxP3‐expressing CD4⁺CD25⁺ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis

References

• Firestein G. S. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356–61
   PubMed Web of Science ®Google Scholar
• Fournier C. Where do T cells stand in rheumatoid arthritis?. Joint Bone Spine 2005; 72: 527–32
   PubMed Web of Science ®Google Scholar
• Leipe J., Skapenko A., Lipsky P. E., Schulze‐Koops H. Regulatory T cells in rheumatoid arthritis. Arthritis Res Ther 2005; 7: 93–9
   PubMed Web of Science ®Google Scholar
• van Amelsfort J. M., Jacobs K. M., Bijlsma J. W., Lafeber F. P., Taams L. S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004; 50: 2775–85
   PubMed Web of Science ®Google Scholar
• Mottonen M., Heikkinen J., Mustonen L., Isomaki P., Luukkainen R., Lassila O. CD4+CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005; 140: 360–7
   PubMed Web of Science ®Google Scholar
• Cao D., Malmstrom V., Baecher‐Allan C., Hafler D., Klareskog L., Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215–23
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Gavin M. A., Rudensky A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330–6
   PubMed Web of Science ®Google Scholar
• Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057–61
   PubMed Web of Science ®Google Scholar
• Kim J. M., Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev 2006; 212: 86–98
   PubMed Web of Science ®Google Scholar
• Kim C. H. Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system. Exp Hematol 2006; 34: 1033–40
   PubMedGoogle Scholar
• Needham D. J., Lee J. X., Beilharz M. W. Intra‐tumoural regulatory T cells: a potential new target in cancer immunotherapy. Biochem Biophys Res Commun 2006; 343: 684–91
   PubMed Web of Science ®Google Scholar
• Wei S., Kryczek I., Zou W. Regulatory T‐cell compartmentalization and trafficking. Blood 2006; 108: 426–31
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Liu M. F., Wang C. R., Fung L. L., Lin L. H., Tsai C. N. The presence of cytokine‐suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 2005; 62: 312–17
   PubMed Web of Science ®Google Scholar
• Tran C. N., Lundy S. K., Fox D. A. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 2005; 12: 183–9
   PubMedGoogle Scholar
• Minami R., Sakai K., Miyamura T., Yamamoto M., Suematsu E. The role of CD4+CD25+ regulatory T cells in patients with rheumatoid arthritis [in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi 2006; 29: 37–42
   PubMedGoogle Scholar
• Hori S., Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 2004; 6: 745–51
   PubMed Web of Science ®Google Scholar
• Cao D., van Vollenhoven R., Klareskog L., Trollmo C., Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004; 6: R335–46
   PubMed Web of Science ®Google Scholar
• Cao D., Borjesson O., Larsson P., Rudin A., Gunnarsson I., Klareskog L., et al. FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints. Scand J Immunol 2006; 63: 444–52
   PubMedGoogle Scholar
• de Kleer I. M., Wedderburn L. R., Taams L. S., Patel A., Varsani H., Klein M., et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172: 6435–43
   PubMed Web of Science ®Google Scholar
• Yurchenko E., Tritt M., Hay V., Shevach E. M., Belkaid Y., Piccirillo C. A. CCR5‐dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med 2006; 203: 2451–60
   PubMed Web of Science ®Google Scholar
• Lim H. W., Broxmeyer H. E., Kim C. H. Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol 2006; 177: 840–51
   PubMed Web of Science ®Google Scholar
• Ishida T., Ishii T., Inagaki A., Yano H., Komatsu H., Iida S., et al. Specific recruitment of CC chemokine receptor 4‐positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 2006; 66: 5716–22
   PubMed Web of Science ®Google Scholar
• Hirahara K., Liu L., Clark R. A., Yamanaka K., Fuhlbrigge R. C., Kupper T. S. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin‐homing receptors. J Immunol 2006; 177: 4488–94
   PubMed Web of Science ®Google Scholar
• Iellem A., Mariani M., Lang R., Recalde H., Panina‐Bordignon P., Sinigaglia F., et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194: 847–53
   PubMed Web of Science ®Google Scholar
• Lee I., Wang L., Wells A. D., Dorf M. E., Ozkaynak E., Hancock W. W. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201: 1037–44
   PubMed Web of Science ®Google Scholar
• Nanki T., Imai T., Nagasaka K., Urasaki Y., Nonomura Y., Taniguchi K., et al. Migration of CX3CR1‐positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 2878–83
   PubMed Web of Science ®Google Scholar
• Nissinen R., Leirisalo‐Repo M., Tiittanen M., Julkunen H., Hirvonen H., Palosuo T., et al. CCR3, CCR5, interleukin 4, and interferon‐gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis. J Rheumatol 2003; 30: 1928–34
   PubMed Web of Science ®Google Scholar
• Norii M., Yamamura M., Iwahashi M., Ueno A., Yamana J., Makino H. Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis. Acta Med Okayama 2006; 60: 149–57
   PubMedGoogle Scholar
• Patel D. D., Zachariah J. P., Whichard L. P. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 2001; 98: 39–45
   PubMed Web of Science ®Google Scholar
• Wang C. R., Liu M. F., Huang Y. H., Chen H. C. Up‐regulation of XCR1 expression in rheumatoid joints. Rheumatology (Oxford) 2004; 43: 569–73
   PubMedGoogle Scholar
• Wang C. R., Liu M. F. Regulation of CCR5 expression and MIP‐1alpha production in CD4+ T cells from patients with rheumatoid arthritis. Clin Exp Immunol 2003; 132: 371–8
   PubMedGoogle Scholar
• Vergunst C. E., van de Sande M. G., Lebre M. C., Tak P. P. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2005; 34: 415–25
   PubMed Web of Science ®Google Scholar